Ecromeximab

From WikiMD.org
Jump to navigation Jump to search

Ecromeximab

Ecromeximab (pronunciation: /ɛkroʊmɛksɪmæb/) is a monoclonal antibody designed for the treatment of various cancer types.

Etymology

The term "Ecromeximab" is derived from the International Nonproprietary Names (INN), where "E" stands for the target species (equine), "crom" is a stem used for tumor targeting, "xi" indicates a chimeric human-mouse antibody, and "mab" is the suffix for monoclonal antibodies.

Usage

Ecromeximab is used in the treatment of various types of cancers, including melanoma, non-small cell lung cancer, and colorectal cancer. It works by binding to the CD166 antigen, a protein often found on the surface of cancer cells, and triggering an immune response against these cells.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski